@PainSteals @lawhern1 Our guideline recommended in favor of offering a trial of opioids to individuals with chronic pain if other options were unhelpful: https://t.co/tSva3onwLk Partly because many patients told us they were willing to accept the low risk
RT @Wanita1: I get so angry when reading the terrible misinformation created &by manipulating wording in regard to the opioid prescribing g…
RT @crystalmurphy28: Where are the studies showing all the people who have lived their life, survived, and managed to take their prescripti…
RT @Wanita1: I get so angry when reading the terrible misinformation created &by manipulating wording in regard to the opioid prescribing g…
RT @crystalmurphy28: Where are the studies showing all the people who have lived their life, survived, and managed to take their prescripti…
RT @Wanita1: I get so angry when reading the terrible misinformation created &by manipulating wording in regard to the opioid prescribing g…
Where are the studies showing all the people who have lived their life, survived, and managed to take their prescription responsibly? Where are the studies showing all the deaths for those not receiving proper medicine/proper care? 🇨🇦🎤🎹✍️📚🎶 #CPP
I get so angry when reading the terrible misinformation created &by manipulating wording in regard to the opioid prescribing guidelines. This group of people need to be held accountable for the suffering they caused. https://t.co/Jdl605Vp5R
If you are able to prescribe in Canada, please take the oat training and provide your patients who use drugs and who are in non cancer pain with the medication they seek Guideline for opioid therapy and chronic noncancer pain | CMAJ https://t.co/p1cG2QkNj
@ml_barnett These two cites to Busse et al (2017) are also both lifted verbatim without quotes https://t.co/Px5gv703QR https://t.co/sXbTtxiXTk
@StefanKertesz You may know all 3 of these studies that are in line w/ your findings, but cpps might not. 1>Canada's 2017 Guideline: non-fatal or fatal OD: “very uncommon” <50 MME (0.1 - 0.14%); "uncommon" 50-90 MME 0.18% and ≥100 MME 0.23%. https://
OD risk to prescribed opioid 0.1%-0.2%: Canada's Rx #Opioid Guideline https://t.co/RK3UgBrdF5 OD risk to prescribed opioid: 0.13%: Von Korff et al for #Kaiser Permanente Washington, Jnl of Pain 2019 https://t.co/yEv1SlNETv
RT @headsUPmigraine: -Rx OD 0.1-0.2%: Canada Rx #Opioid Guideline (2017) https://t.co/u60SgAVxjl -99.4% addiction rate: Brat et al. Post-O…
-Rx OD 0.1-0.2%: Canada Rx #Opioid Guideline (2017) https://t.co/u60SgAVxjl -99.4% addiction rate: Brat et al. Post-Op #Opioid Rx & Misuse. BMJ. 2018 Jan 17;360:j5790. https://t.co/iNJ9Nibd91
0.1% to 0.23% = risk of OD to prescribed #opioids, per Canada's 2017 Guideline. 0.1% for <20 MED, 0.14% for 20–49, 0.18% for 50–99 MED, 0.23% for ≥100 MED. Discontinuation carries a significantly higher risk of death. #PCP #MedicalTwitter https://t
@LynnJackson412 @headsUPmigraine --Canada's rate of OD to prescribed #opioids is 0.2%. https://t.co/RK3UgBrdF5 -- #Kaiser's 2019 study was conducted in the US & found a rate of OD in medical use of 0.13%. https://t.co/yEv1SlNETv
RT @NickCarlin6: Truth Comes Out, Yet we are STILL tortufed?
@NisaNite @ravensspirit68 OD stats in Canada's rx #opioid guideline MME/day: 0.1% for < 20 0.14% for 20–49 0.18% for 50–99 0.23% for ≥ 100 - that's less than 1/4 of 1% - & everyone on 100+ isn't equally at risk. Dose variation itself more than
RT @NickCarlin6: Truth Comes Out, Yet we are STILL tortufed? https://t.co/TK654Hgjfq
RT @NickCarlin6: Truth Comes Out, Yet we are STILL tortufed?
RT @JillPiggott: Risk of OD in medical use of #opioids is highest in doses ≥100 MME but still less than one quarter of 1% (0.23%). Canadia…
@JSG_54 @headsUPmigraine @NitaGhei @hope411adcock @PROPkills @StopBadDocs @DEEGILES0410 @ReeseSTyrell @NickCarlin6 @threadreaderapp Here's Canada's 2017 Guideline: "Some patients may have a substantial increase in pain or decrease in function that persists
RT @JillPiggott: Risk of OD in medical use of #opioids is highest in doses ≥100 MME but still less than one quarter of 1% (0.23%). Canadia…
RT @NickCarlin6: Truth Comes Out, Yet we are STILL tortufed?
Canada's Guideline for #Opioid Therapy 2017 https://t.co/RK3UgBrdF5
RT @JillPiggott: Risk of OD in medical use of #opioids is highest in doses ≥100 MME but still less than one quarter of 1% (0.23%). Canadia…
RT @JillPiggott: Risk of OD in medical use of #opioids is highest in doses ≥100 MME but still less than one quarter of 1% (0.23%). Canadia…
RT @JillPiggott: Risk of OD in medical use of #opioids is highest in doses ≥100 MME but still less than one quarter of 1% (0.23%). Canadia…
RT @JillPiggott: Risk of OD in medical use of #opioids is highest in doses ≥100 MME but still less than one quarter of 1% (0.23%). Canadia…
RT @NickCarlin6: Truth Comes Out, Yet we are STILL tortufed?
RT @JillPiggott: Risk of OD in medical use of #opioids is highest in doses ≥100 MME but still less than one quarter of 1% (0.23%). Canadia…
RT @JillPiggott: Risk of OD in medical use of #opioids is highest in doses ≥100 MME but still less than one quarter of 1% (0.23%). Canadia…
RT @JillPiggott: Risk of OD in medical use of #opioids is highest in doses ≥100 MME but still less than one quarter of 1% (0.23%). Canadia…
Risk of OD in medical use of #opioids is highest in doses ≥100 MME but still less than one quarter of 1% (0.23%). Canadian Guideline for Opioid Therapy (2017) thread: 3 studies on #suicide, OD, & rx opioids https://t.co/RK3UgBrdF5
@amy_schmalz @nytimes @afrakt SAME PEOPLE who criticized CDC 2016 produced Canada's 2017 Guide calling for tapers in even stronger language than CDC 2016! Of course, US policymakers & doctors didn't actually read CDC 2016, so #pain patients across N Am
RT @JillPiggott: @GhanaboyPharmd Canada's 2017 Guideline: Overdose rates in medical use of #opioids (MME per day): < 20 mg: 0.1% 20–49…
@GhanaboyPharmd Canada's 2017 Guideline: Overdose rates in medical use of #opioids (MME per day): < 20 mg: 0.1% 20–49 mg: 0.14% 50–99 mg: 0.18% ≥ 100 mg: 0.23% https://t.co/RK3UgBrdF5
@Dana_Runge @JoeAllenNewman #Canada's 2017 #opioid guideline: studies show 11.1% of patients had a reduction in #pain & 10% achieved “an important improvement in function.” #OD risk/MME per day: 0.1% =< 20 mg, 0.14% = 20–49, 0.18% = 50–99 mg, 0.23
@AjayManhapra Dr Manhapra--I'm rereading the NICE thread. Canada's 2017 Guideline is premised on research that found rx #opioids provide 11.1% of people #pain reduction & 10% "important improvement in function." They cite a 5.5% rate of #addiction. htt
Overdose is “very uncommon” in people prescribed less than 50 MME & “uncommon” in those taking 50–90 MME, acc'g to Canadian 2017 #Opioid Guidelines. MME/day OD rates: 0.1% for <20 MME; 0.14% for 20–49 MME, 0.18% for 50–99 MME, 0.23% for ≥ 100 MME.
@CanadaPain @CIAAG_Lauren @NitaGhei @headsUPmigraine 2017 Canadian Guideline recommends a trial of #opioids for people "who have persistent problematic pain despite optimized nonopioid therapy" if they don't have past or current substance abuse or an activ
@hope411adcock Busse, Craigie, Juurlink, et al. [Canadian] Guideline for #opioid therapy & chronic non-cancer pain. CMAJ. 2017 May 8; 189(18):E659-E666. https://t.co/RK3UgBrdF5
RT @EBCPMcMaster: There is one clearly best guideline for use of opioids in patients with non-cancer pain that addresses the evidence and s…
RT @EBCPMcMaster: There is one clearly best guideline for use of opioids in patients with non-cancer pain that addresses the evidence and s…
There is one clearly best guideline for use of opioids in patients with non-cancer pain that addresses the evidence and strikes the right balance between under- and over-prescription. #guideline #opioids https://t.co/XMGFga59st https://t.co/NesrZu3uSS
@edsoriano53 @CMerandi @headsUPmigraine NO North American association of pain experts supports forced tapers or bans on opioids for chronic pain. Their guidelines are evidence-based. For ex: https://t.co/RK3UgBrdF5
RT @EBCPMcMaster: By far the most trustworthy guideline for opioid use in patients with chronic non-cancer pain. #opioid #pain https://t.co…
By far the most trustworthy guideline for opioid use in patients with chronic non-cancer pain. #opioid #pain https://t.co/Q12ZfyMucv https://t.co/kYbQJZZ3kE
@VetMe2020 @LelenaPeacock @DawsonInga @CayleeCresta @SpicyPurritos @cmoHHS This is a physician who is NOT up to date. https://t.co/1grpQ3gPrG
@jovtsang @HealthWatch123 I think the guideline referred to in the article is this one from 2017 https://t.co/rd21XyBVda
Guía para el tratamiento con opiodes y el dolor crónico no oncológico de los Canadienses, 2017. Guideline for opioid therapy and chronic noncancer pain https://t.co/lEAVllqQZD
RT @DavidJuurlink: Thanks to the good people at @CMAJ for making this open access. No, the new Canadian guideline does not recommend manda…
RT @DavidJuurlink: Thanks to the good people at @CMAJ for making this open access. No, the new Canadian guideline does not recommend manda…
RT @DavidJuurlink: Thanks to the good people at @CMAJ for making this open access. No, the new Canadian guideline does not recommend manda…
RT @DavidJuurlink: Thanks to the good people at @CMAJ for making this open access. No, the new Canadian guideline does not recommend manda…
RT @DavidJuurlink: Thanks to the good people at @CMAJ for making this open access. No, the new Canadian guideline does not recommend manda…
RT @DavidJuurlink: Thanks to the good people at @CMAJ for making this open access. No, the new Canadian guideline does not recommend manda…
RT @DavidJuurlink: Thanks to the good people at @CMAJ for making this open access. No, the new Canadian guideline does not recommend manda…
RT @DavidJuurlink: Thanks to the good people at @CMAJ for making this open access. No, the new Canadian guideline does not recommend manda…
RT @DavidJuurlink: Thanks to the good people at @CMAJ for making this open access. No, the new Canadian guideline does not recommend manda…
RT @DavidJuurlink: Thanks to the good people at @CMAJ for making this open access. No, the new Canadian guideline does not recommend manda…
RT @DavidJuurlink: Thanks to the good people at @CMAJ for making this open access. No, the new Canadian guideline does not recommend manda…
Thanks to the good people at @CMAJ for making this open access. No, the new Canadian guideline does not recommend mandatory opioid tapers. New link: https://t.co/z4skUHcF8q
We respond to the myth that the 2017 Canadian opioid guideline recommends mandatory tapering - it does not (link without paywall): https://t.co/kvg77K6gqs
@NicoleInPain @voxdotcom The trial referred to was conducted among "severe chronic back pain, or hip or knee osteoarthritis, for at least six months." @juliaoftoronto makes that clear. Long-term opioid use for other conditions is not first line Rx. See htt
More research regarding chiropractic in the management of chronic pain! https://t.co/zMY5zlRGew
@the_lissa @TheSpec Take a read of this. Also valuable to check the CPSO website and see how many MDs are being reprimanded for over-prescribing of narcotics https://t.co/bzQLMMpLoX
Canadian Guideline for opioid therapy and chronic noncancer pain #Chronicpain https://t.co/ngTe87PLCn
RT @dlkelsall: Sobering study in @CMAJ_Open, given the #opioidepidemic. While at #myfmf, check out the session (F105) on the Canadian opioi…
RT @dlkelsall: Sobering study in @CMAJ_Open, given the #opioidepidemic. While at #myfmf, check out the session (F105) on the Canadian opioi…
RT @dlkelsall: Sobering study in @CMAJ_Open, given the #opioidepidemic. While at #myfmf, check out the session (F105) on the Canadian opioi…
RT @dlkelsall: Sobering study in @CMAJ_Open, given the #opioidepidemic. While at #myfmf, check out the session (F105) on the Canadian opioi…
Sobering study in @CMAJ_Open, given the #opioidepidemic. While at #myfmf, check out the session (F105) on the Canadian opioid guideline @CMAJ https://t.co/JGtx6p3XWF https://t.co/wzkgHibLA0
RT @UWS_news: Guideline published in the #Canadian Medical Association Journal (CMAJ) encourages non-drug therapies. Read more: https://t.c…
Guideline published in the #Canadian Medical Association Journal (CMAJ) encourages non-drug therapies. Read more: https://t.co/aHXqgpO3eM https://t.co/ejOvBD6v6P
Guideline for opioid therapy and chronic noncancer pain https://t.co/WC37SMZE29 via @CMAJ #opioids #painmanagement
Guideline published in the #Canadian Medical Association Journal (CMAJ) encourages non-drug therapies. Read more: https://t.co/aHXqgpO3eM https://t.co/VqdzCpwKdz
RT @DavidJuurlink: @HillPharmD @ThomasKlineMD @KirbyLana @GoneHiking70 @StefanKertesz @SubstanceAbuseJ Canadian guideline was considerably…
RT @DavidJuurlink: @HillPharmD @ThomasKlineMD @KirbyLana @GoneHiking70 @StefanKertesz @SubstanceAbuseJ Canadian guideline was considerably…
RT @DavidJuurlink: @HillPharmD @ThomasKlineMD @KirbyLana @GoneHiking70 @StefanKertesz @SubstanceAbuseJ Canadian guideline was considerably…
@HillPharmD @ThomasKlineMD @KirbyLana @GoneHiking70 @StefanKertesz @SubstanceAbuseJ Canadian guideline was considerably more thorough & generated similar dose recs. https://t.co/ZRO9EXIZJH https://t.co/yKvm1JGFBn
Guideline published in the #Canadian Medical Association Journal (CMAJ) encourages non-drug therapies. Read more: https://t.co/aHXqgpO3eM https://t.co/2zFdHVJDv1
RT @tripdatabase: New2Trip: Guideline for opioid therapy & chronic noncancer pain https://t.co/eJ3ZdKiu8x
New2Trip: Guideline for opioid therapy & chronic noncancer pain https://t.co/eJ3ZdKiu8x
RT @ChristineSoong: Check out the new opioid guidelines - comes with an online app, and created with a panel patient advisors. https://t.co…
RT @ChristineSoong: Check out the new opioid guidelines - comes with an online app, and created with a panel patient advisors. https://t.co…
Pharmacist role important in opioid therapy...!! https://t.co/Yhs65SsmO6
RT @DavidJuurlink: Just out: Updated Canadian guideline for opioid prescribing in chronic noncancer pain https://t.co/tlYyl5kE56 in @CMAJ
RT @OPHLA: The full guideline and additional tools are available at: https://t.co/Ml2JVa08yq https://t.co/2DeaNoSuhc
RT @EBCPMcMaster: Trustworthy #opioid guideline for chronic non cancer pain, rigorous GRADE methodology, explicit values & preferences http…
Trustworthy #opioid guideline for chronic non cancer pain, rigorous GRADE methodology, explicit values & preferences https://t.co/pRwsdRaBSw
New2Trip: Guideline for opioid therapy & chronic noncancer pain https://t.co/eJ3ZdKiu8x
RT @AETSA_: #GPC #opiodes en #dolor_crónico no oncológico https://t.co/qe8LxbGBEG @GuiaSalud @semfyc @Sociedad_SEMI
RT @AETSA_: #GPC #opiodes en #dolor_crónico no oncológico https://t.co/qe8LxbGBEG @GuiaSalud @semfyc @Sociedad_SEMI
RT @UWS_news: Guideline published in the #Canadian Medical Association Journal (CMAJ) encourages non-drug therapies. Read more: https://t.c…
Guideline published in the #Canadian Medical Association Journal (CMAJ) encourages non-drug therapies. Read more: https://t.co/aHXqgq5E6k https://t.co/txiKfVTq3Y
RT @AETSA_: #GPC #opiodes en #dolor_crónico no oncológico https://t.co/qe8LxbGBEG @GuiaSalud @semfyc @Sociedad_SEMI
#GPC #opiodes en #dolor_crónico no oncológico https://t.co/qe8LxbGBEG @GuiaSalud @semfyc @Sociedad_SEMI